Evidence map›Paper›PMID 41079561›Full record

ArticleSchizophrenia research. Cognition2026

Premorbid functioning trajectories and the one-year course of cognitive performance in first-episode psychosis: a cluster analysis in PSYSCAN.

Margot I E Slot, Hendrika H van Hell, Inge Winter-van Rossum, George Gifford, Paola Dazzan, Arija Maat, Lieuwe De Haan, Benedicto Crespo-Facorro, Birte Y Glenthøj, Colm McDonald and 12 more

Abstract read
In one paragraph

Article in Schizophrenia research. Cognition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Margot I E SlotDepartment of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.
Hendrika H van HellDepartment of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.
Inge Winter-van RossumDepartment of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.
George GiffordDepartment of Psychiatry, University of Oxford, Warneford Hospital, Oxford, United Kingdom.
Paola DazzanDepartment of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, De Crespigny Park, Denmark 458 Hill, London, SE5 8AF, United Kingdom.
Arija MaatDepartment of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.
Lieuwe De HaanAmsterdam UMC, University of Amsterdam, Psychiatry, Department Early Psychosis, Amsterdam, Meibergdreef 9, the Netherlands.
Benedicto Crespo-FacorroHospital Universitario Virgen del Rocio, CIBERSAM, IBiS-CSIC, Department of Psychiatry, School of Medicine, University of Sevilla, Spain.
Birte Y GlenthøjCentre for Neuropsychiatric Schizophrenia Research (CNSR), Centre for Clinical Intervention and Neuropsychiatric Schizophrenia Research (CINS), Mental Health Centre Glostrup, Glostrup, Denmark.
Colm McDonaldCentre for Neuroimaging & Cognitive Genomics (NICOG), NCBES Galway Neuroscience Centre, National University of Ireland Galway, H91 TK33, Galway, Ireland.
Thérèse van AmelsvoortDepartment of Psychiatry and Neuropsychology, Maastricht University, Maastricht, the Netherlands.
Celso ArangoDepartment of Child and Adolescent Psychiatry, Institute of Psychiatry and Mental Health, Hospital General Universitario Gregorio Marañón, IiSGM, CIBERSAM, ISCIII, School of Medicine, Universidad Complutense, Madrid, Spain.
Irina FalkenbergDepartment of Psychiatry, University of Marburg, Rudolf-Bultmann-Straße 8, D-35039, Marburg, Germany.
Barnaby NelsonOrygen, Melbourne, VIC, Australia.
Silvana GalderisiDepartment of Mental and Physical Health and Preventive Medicine, University of Campania L. Vanvitelli, Naples, Italy.
Mark WeiserZachai Department of Psychiatry, Sheba Medical Center, Tel Hashomer, 52621, Israel.
Gabriele SachsDepartment of Psychiatry and Psychotherapy, Medical University of Vienna, 1090, Vienna, Austria.
Anke MaatzDepartment of Adult Psychiatry and Psychotherapy, Psychiatric University Clinic Zurich, University of Zurich, Switzerland.
Jun Soo KwonDepartment of Psychiatry, Hanyang University Hospital, 222-1 Wangsimni-ro, Seongdong-gu, Seoul, Republic of Korea.
PSYSCAN Consortium
Philip McGuireDepartment of Psychiatry, University of Oxford, Warneford Hospital, Oxford, United Kingdom.
René S KahnDepartment of Psychiatry, UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: We examined the course of cognitive performance in first-episode psychosis (FEP) compared to healthy controls (HC), and whether this varied across subgroups of patients defined by premorbid functioning (PMF) trajectories, using a clustering approach. Methods: Data were collected in 302 FEP and 136 HC subjects participating in PSYSCAN (HEALTH.2013.2.2.1-2-FEP). K-means clustering (Euclidean distance) was used to cluster longitudinal trajectories of different PMF domains simultaneously. Since PMF was assessed retrospectively using the Premorbid Adjustment Scale (PAS), findings should be interpreted with caution, although PAS ratings have shown reasonable validity against prospective data. Results: As expected, FEP showed impaired performance across all cognitive domains compared to HC. We identified four trajectories of PMF: a normal premorbid developmental trajectory (globally-normal, 21 %), stable intermediate PMF across domains (stable-intermediate, 29 %), stable poor or deteriorating PMF in the academic domain (normal-social/poor-academic, 29 %), and a globally impaired group with poor/deteriorating PMF across domains (globally-poor, 21 %). These clusters showed distinct levels of post-onset impairments in sustained visual attention, visual working memory and emotion recognition. Conclusions: This study confirms a positive association between PMF and cognitive performance in the early years following psychosis onset. It aligns with findings that individuals later diagnosed with schizophrenia already show developmental deficits/lags from childhood to early adolescence compared to normally developing children. As PMF can be considered a proxy for cognitive reserve, our results suggest that higher reserve acts as a buffer against cognitive decline and supports better performance on sustained visual attention, complex visual working memory, and aspects of emotion recognition.

Indexed as

ClusteringCognitionFEPPremorbid functioningPsychosisSchizophrenia

Identifiers

PMID41079561
PMCPMC12508902

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.